CoChat

Therapy and clinical trials in frontotemporal dementia: past, present, and future

Open access
Tsai, Richard M., Boxer, Adam L. · 2016 · Journal of Neurochemistry
Cited by 143

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Abstract

Frontotemporal dementia (FTD) is a common form of dementia with heterogeneous clinical presentations and distinct clinical syndromes. This article will review currently available therapies for FTD, its related disorders and their clinical evidence. It will also discuss recent advancements in FTD pathophysiology, treatment development, biomarker advancement and their relation to recently completed or currently ongoing clinical trials as well as future implications. image Frontotemporal dementia (FTD) is a type of dementia with distinct clinical syndromes. Current treatments involve off‐label use of medications for symptomatic management and cannot modify disease course. Advancements in FTD pathophysiology, genetics, and biomarkers have led to development of small molecules targeting the underlying pathology in hopes of achieving a disease‐modifying effect. This article will review current therapies for FTD, discuss advancements in FTD pathophysiology, therapy development, biomarker advancement, their relation to recent clinical trials and future implications. This article is part of the Frontotemporal Dementia special issue.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jnc.13640

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 43 references

Research works printed but not linked: 76

  1. 10.1007/s10072-014-1683-y · DOI
  2. 10.1021/bi00158a027 · DOI · Paper page
  3. 10.1016/j.neurobiolaging.2015.06.008 · DOI
  4. 10.1176/appi.neuropsych.12060158 · doi:10.1176/appi.neuropsych.12060158
  5. 10.1016/j.neuron.2013.02.004 · DOI · Paper page
  6. 10.1016/S0140-6736(15)00461-4 · DOI · Paper page
  7. 10.1002/mds.10211 · DOI
  8. 10.1097/WAD.0b013e318197852f · DOI · Paper page
  9. 10.1136/jnnp.2009.204081 · DOI · Paper page
  10. 10.1016/j.jalz.2012.03.003 · DOI · Paper page
  11. Brunden K. R., 2013, Microtubule‐stabilizing agents as potential therapeutics for neurodegenerative disease, Bioorg. Med. Chem., 5, 5040
  12. 10.1111/j.1750-3639.1999.tb00550.x · DOI · Paper page
  13. 10.1523/JNEUROSCI.5757-10.2011 · DOI · Paper page
  14. 10.3233/JAD-132477 · DOI · Paper page
  15. 10.1074/jbc.M110.193433 · DOI · Paper page
  16. 10.1074/jbc.M111.229633 · DOI · Paper page
  17. 10.1016/j.jagp.2013.01.060 · DOI · Paper page
  18. 10.1177/153331750201700504 · DOI · Paper page
  19. 10.1073/pnas.1301175110 · DOI · Paper page
  20. 10.1093/brain/awu213 · DOI · Paper page
  21. 10.1097/WNN.0b013e31816bdf73 · DOI · Paper page
  22. 10.1097/00004714-200006000-00018 · DOI · Paper page
  23. Dani M., 2015, Tau imaging in neurodegenerative diseases, Eur. J. Nucl. Med. Mol. Imaging, 16, 1139
  24. 10.1007/s00213-003-1686-5 · DOI · Paper page
  25. 10.1091/mbc.3.10.1141 · DOI · Paper page
  26. 10.1016/j.brainres.2012.02.030 · DOI · Paper page
  27. 10.1034/j.1600-0404.2001.103002123.x · DOI · Paper page
  28. 10.1097/00005072-199601000-00006 · DOI · Paper page
  29. 10.1080/15622970601016538 · DOI · Paper page
  30. 10.1093/brain/awn352 · DOI · Paper page
  31. 10.1212/WNL.0000000000001133 · DOI · Paper page
  32. 10.1002/ana.20365 · DOI · Paper page
  33. 10.1111/nan.12213 · DOI · Paper page
  34. 10.1212/01.wnl.0000325058.10218.fc · DOI · Paper page
  35. 10.1093/brain/awm032 · DOI · Paper page
  36. 10.1159/000439521 · DOI
  37. 10.1212/WNL.0b013e31821103e6 · DOI · Paper page
  38. 10.1097/JGP.0b013e31823033f3 · DOI
  39. 10.4088/JCP.v69n1219a · DOI · Paper page
  40. Kaye E. D., 2010, Frontotemporal dementia and pharmacologic interventions, J. Neuropsychiatry Clin. Neurosci., 22, 19, 10.1176/jnp.2010.22.1.19 · DOI
  41. 10.1111/j.1447-0594.2012.00956.x · DOI
  42. 10.1159/000114065 · doi:10.1159/000114065
  43. 10.1007/s00415-015-7657-z · DOI
  44. 10.1001/archneur.55.8.1099 · doi:10.1001/archneur.55.8.1099
  45. 10.1073/pnas.1318835110 · DOI · Paper page
  46. 10.1159/000077171 · DOI · Paper page
  47. 10.1002/ana.22424 · DOI · Paper page
  48. 10.1016/j.jalz.2009.04.1231 · DOI · Paper page
  49. 10.1212/WNL.57.3.467 · DOI · Paper page
  50. 10.1212/WNL.0000000000001642 · DOI · Paper page
  51. 10.1002/mds.20465 · DOI · Paper page
  52. 10.1097/WAD.0b013e31815bf774 · DOI · Paper page
  53. 10.1159/000067021 · DOI · Paper page
  54. 10.1177/153331750301800410 · DOI · Paper page
  55. 10.2165/00002512-200421140-00003 · DOI
  56. 10.1212/01.wnl.0000259519.78480.c3 · DOI · Paper page
  57. 10.1136/jnnp.2010.238899 · DOI
  58. 10.1002/gps.774 · DOI · Paper page
  59. 10.1097/JCP.0b013e31823f91b9 · DOI
  60. 10.1159/000051219 · DOI · Paper page
  61. 10.1136/jnnp.2009.173260 · DOI
  62. 10.1097/01.jcp.0000426190.64916.3b · DOI
  63. 10.1212/01.wnl.0000172911.39167.b6 · DOI · Paper page
  64. 10.1212/01.WNL.0000158425.46019.5C · DOI · Paper page
  65. 10.1186/alzrt149 · DOI
  66. 10.1111/j.1479-8301.2012.00429.x · DOI
  67. 10.1155/2013/547853 · DOI
  68. 10.1002/ana.21621 · DOI · Paper page
  69. 10.1097/WAD.0b013e318047df5d · DOI · Paper page
  70. 10.4088/JCP.v58n0506 · DOI · Paper page
  71. 10.1016/S1474-4422(08)70194-7 · DOI · Paper page
  72. 10.1001/jama.291.3.317 · DOI · Paper page
  73. 10.3233/JAD-2010-101632 · DOI · Paper page
  74. 10.1016/j.parkreldis.2011.10.013 · DOI · Paper page
  75. Yang Y., 2001, Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation. Immunocytochemical and quantitative study using a graph method, Acta Neuropathol., 101, 256, 10.1007/s004010000293 · DOI
  76. 10.1002/ana.10222 · DOI · Paper page

Cited by

Metadata

Authors
Tsai, R. M., & Boxer, A. L.
Venue
Journal of Neurochemistry
Publisher
Wiley
Published
2016-06-15
Volume
138
Issue
S1
Pages
211-221
ISSN
  • 0022-3042 (ISSN-L)
  • 1471-4159
OpenAlex
W2443339653
Cited by
143
References
43
FWCI
11.38
Type
journal article
Language
en
Open access
bronze
Funders
National Institutes of Health (U54NS092089, R01AG038791)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.